Folic acid
1 mg № 50
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Tablets
ATC code
B03BB01
RX/OTC
RX
Registration certificate
UA/4380/01/01
General properties
Pharmacotherapeutic group
Anti-anaemic preparations. Folic acid and its derivatives.
Therapeutic indications
- Treatment and prevention of anaemia due to folic acid deficiency: macrocytic anaemia, anaemia and leukopenia which are drug-induced or caused by ionizing radiation; megaloblastic anaemia, post-resection anaemia and sideroblastic anaemia in elderly patients; anaemia due to diseases of the small intestine, sprue and malabsorption syndrome;
- Prevention of birth defects in the foetus: neural tube defects, hydrocephalus, cleft palate, cleft lip and cephalocele;
- Long-term treatment with folic acid antagonists (methotrexate, trimethoprim-sulfamethoxazole combination), anticonvulsants (phenytoin, primidone, phenobarbital);
- folic acid deficiency associated with an unbalanced diet or malnutrition;
- Treatment of male infertility due to a decrease in spermatogenesis (oligospermia);
- Polyneuritis and polyneuropathy, including alcoholic etiology.
Contraindications
Hypersensitivity to folic acid or other components of the drug, malignant neoplasms, malignant anaemia, untreated cobalamin deficiency.
Pharmaceutical characteristics
Main physicochemical properties
1 mg tablets – flat-faced bisect, light yellow to yellow tablets.
Shelf life
3 years.
Storage
Store in original packaging at temperatures not exceeding 25 °C.
Keep out of the reach of children.
Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
